MEDICAL DIAGNOSTICS: Cell elasticity can predict metastasis

Aug. 1, 2005
By comparing the difference in elasticity between malignant and nonmalignant cells, a new laser-based cancer test may be able to determine whether cancer has spread, and thus reduce the number of unnecessary mastectomies in women with breast cancer.

By comparing the difference in elasticity between malignant and nonmalignant cells, a new laser-based cancer test may be able to determine whether cancer has spread, and thus reduce the number of unnecessary mastectomies in women with breast cancer. Josef Käs, director of the Institute for Soft Matter Physics at the University of Leipzig, Germany, and Jochen Guck, a researcher there, have developed a shoebox-size laser-based “optical stretcher” that measures a cell’s elasticity, instead of its biological makeup, to determine whether the cell is cancerous.

Cancer cells tend to dedifferentiate, losing the special characteristics of the organ in which they started life. Thus, they no longer need the rigid cytoskeleton that holds them in shape, making them more elastic than normal cells (see figure).

“A healthy cell is like a Gummi Bear, with a cytoskeleton like tent poles,” Käs said. “If it is cancerous, it loses the tent poles and becomes a fluid bag. And the softer the cancer cells, the more likely they are to travel through the body and produce secondary tumors (metastases).”

In the absence of a strong cytoskeleton, cancerous cells extend 40% more easily than their healthy counterparts, according to Käs. Cells from metastasized tumors are an additional 30% more elastic than early-stage cancer cells. Thus, the laser-based optical-stretcher method could potentially assess how far the disease has advanced and determine metastasis based on cell elasticity alone. While cancer-causing genes produce a small change in a cell’s structural proteins, the cell’s elasticity properties undergo dramatic changes, according to Käs. Given a sample that contains at least 50 tumor cells, the laser can spot cancer more than 90% of the time.

Fast measurement

The optical stretcher uses a beam of IR laser light (1060 or 800 nm) to test the physical strength of each cell, measure the progress of a cancer by examining only the primary tumor, and provide a diagnosis using as few as 50 cells, instead of the 10,000 to 100,000 required by other methods. With such small samples, diagnoses can be made even before solid tumors develop or where a traditional biopsy is problematic. Because it can test as many as 3600 cells per minute, the optical stretcher is fast enough to be useful in clinical diagnosis. The sample is measured in two hours and provides a distribution of all of the stretchiness of the cells in four hours. Käs started with a Ti:sapphire laser, but found a 1060-nm fiber laser more in line with cost considerations for a medical device.

As Käs explained, the cell is pretty much transparent, so light is not reflected or absorbed. When a laser beam from the device enters a cell, the light gains momentum because of the different conditions inside. According to the law of conservation of momentum, the cell must lose an equal but opposite amount, so its membrane bends towards the light source.

“The cell gets a kick backward,” Käs said. “When the laser light leaves the cell, it loses momentum and drags the cell’s opposite edge along with it. By applying a continuous beam, the cell gets stretched to its limit.”

The optical stretcher differs from optical tweezers, in which the light is focused to a sharp point to grab hold of a cell. Because the optical stretcher does not use focused light, laser beams strong enough to detect stretching can be used without killing the cell. The microfluidic chamber uses two fiber lasers or splits light from a single fiber laser in two. The configuration is a simple optical trap. The system can be set up on any cell-culture microscope using a CCD camera, a microfluidic pump system or syringe pump, a fiber laser, and a computer to control the procedure.

Other potential uses for the optical stretcher include diagnosing oral cancer and locating stem cells.

About the Author

Ilene Schneider | Freelance writer

Ilene Schneider is a freelance writer living in Irvine, CA.

Sponsored Recommendations

Video: December 8, 2023 Photonics Hot List

Dec. 8, 2023
In this episode, we cover a microscopy method that hits uncharted cell territory, drone-based imaging for solar farm inspection, soliton microcombs that boost conversion efficiency...

China’s industrial laser market shows steady growth in turbulent times

Dec. 8, 2023
This in-depth market update focuses on trends in laser processing and industrial lasers while touching on what to expect in the ultrafast laser, fiber laser, LiDAR, and handheld...

What does it take to land venture capital for photonics-driven startups?

Dec. 7, 2023
Capital to grow a startup company can come from many sources: contract and non-recurring engineering (NRE) funding, angels and friends, customer upfront payments, and venture ...

Looking beyond the incremental: Reimagining optical devices

Dec. 7, 2023
Rob Devlin, co-founder and CEO of Metalenz, shares the significant people that forged his path to developing one of the most promising optics companies in the world today.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!